The objective of this funding opportunity is  to bring together technologies and services to create Information and Communication Technology (ICT) based solutions with a clear route to market that will enable the wellbeing of people with dementia and their communities (family, caregivers, neighbourhood, service providers, care system, etc.).

For more information, please consult the Active and Assisted Living website.

Active and Assisted Living (AAL) Programme Call 2016

Living Well with Dementia

Application Deadline: May 26, 2016           

Anticipated Notice of Decision: November 30, 2016

Funding Start Date: October 1, 2016

Funds Available: The total Canadian amount available for this funding opportunity is $706,000 (CAD) enough to fund approximately two (2) grants. This amount may increase if additional funding partners participate.

• CIHR will contribute up to $117,666 (CAD) per year for 1 grant for a maximum of three years.
• AGE-WELL NCE will contribute up to $117,666 (CAD) per year for 1 grant for a maximum of three years.

The focus of the 2016 Call Challenge of the AAL Programme is to fund information and communication technology (ICT) based innovative, transnational and multi-disciplinary collaborative projects with a clear route to market that support people with dementia and their caregivers to live in dignity and provide satisfaction through all stages of dementia.

Eligibility: Consortium composition of at least 3 independent eligible organizations (legal entities), from at least 3 different AAL Partner States participating in the Call for Proposals; English as the language of the proposal

Partner countries: Austria, Belgium, Canada, Cyprus, Denmark,  France, Hungary, Ireland, Israel, Italy, Luxembourg, Netherlands, Norway, Poland, Romania, Portugal, Slovenia, Spain, Sweden, Switzerland and the United Kingdom.

CIHR Canadian Eligibility Requirements

A Partner Matching Tool is available to connect with other partner states. 
 

Information day: An informational webcast will be available online within a few days of March 8, 2016.

Info Day Webcast

AAL

The Active and Assisted Living (AAL) Programme is a common funding activity of member states of the AAL Association, with the financial support of the European Commission, based on article 185 of the Treaty on the Functioning of the European Union. The AAL Programme calls are complementary to the Horizon 2020 calls related to Active and Healthy Ageing under Societal Challenge 1.

The AAL Call 2016 is part of the AAL Programme that was approved in May 2014 by the European Parliament and the Council of the European Union. As part of the work-programme, the AAL is launching a Call for Proposals: “Living well with dementia: Providing integrated solutions based on information and communication technology to support the wellbeing of people living with dementia and their communities.”

Grand Challenges China: New Interventions for Global Health.  This challenge focuses on calls for innovative concepts for safe, effective, affordable and widely utilized interventions, such as vaccines and therapeutics, with the potential to protect against the acquisition, progression or transmission of infectious diseases that disproportionately affect the world’s poorest.  This call is in partnership with the National Natural Science Foundation of China and requires substantive collaborations between China-based investigators and those based outside of China.

Application deadline is March 15, 2016, 8:00 am Beijing time (March 14, 2016, 5pm Seattle time). For a detailed description of this challenge, please visit the Grand Challenges site.

This Knowledge to Action Grant has been created to encourage ideas that will close the gap between what is known from research and what is done with that knowledge in the health care community and public health practice. These grants are intended to provide funding for research projects that build on existing cancer research findings and aim to improve outcomes and experiences through knowledge translation (KT) for people and populations at risk, patients, their families and communities across the cancer trajectory e.g., to assist knowledge users (researchers, practitioners, policy makers, CCS program delivery staff and/or volunteers) in their awareness of knowledge or innovations and facilitating their use in health or healthcare system improvement. The grant should incorporate the principles of knowledge translation including knowledge synthesis, dissemination, exchange and/or ethically sound application of knowledge to improve health and the health system.

The goal of this grant program is to support and accelerate research and the application of new knowledge with imminent application potential relevant to cancer prevention in human populations. Proposed projects must demonstrate a specific and defined potential for impact on cancer incidence, for example through prevention/risk reduction research, programs, and practice, including interventions, knowledge translation, best practices and health-related decision making at the individual, organizational and health system levels. Applications are invited for social/psychosocial and behavioural science, health policy, population health, health promotion and health services research aimed at cancer prevention.

• Development of new methods for rapid multi-pathogen/multi-phenotype detection of multidrug-resistant organisms (MDROs) and nosocomial pathogens, and/or characterization of antimicrobial resistance patterns.
• Development of assays for host immune response biomarkers for diagnosis or prognosis.
• Development and preclinical testing of novel chemotypes (chemical classes/materials), biologics as potential therapeutics or prophylactics for wound infection, and/or biofilm formation, maintenance, or propagation.

• Evaluation of optimum preventive or directive therapies for combat-related or trauma-induced wound infections using Food and Drug Administration-approved drugs, biologics, or devices either alone or in combination.
• Evaluation of a functional prototype device or assay for the rapid detection of pathogens and/or microbial drug resistance markers.
• Evaluation of a functional prototype device or assay for the rapid detection of novel and specific in vivo or in vitro biomarkers (from wound, serum, saliva, or urine) that predict development of infection or discriminate between infection and colonization.

• Independent investigators at all academic levels (or equivalent).
• Both intramural and extramural investigators are encouraged to apply.

• A pre-application is required

• The FY17 MID-ARA intent is to support hypothesis-testing and/or proof-of-concept studies in in vitro and/or in vivo models, concept refinement, product candidate evaluation, maturation and/or down-selection, or completion of studies in support of IND/IDE applications.

• The anticipated funding limit is $2.0M total costs.

• The anticipated maximum period of performance is 3 years.

• Independent investigators at all academic levels (or equivalent). Both intramural and extramural investigators are encouraged to apply.

• A pre-application is required

• The FY17 MID-CTA intent is to support early phase clinical trials and medical device (including diagnostics) testing with the potential to have a major impact on prevention and treatment of combat-related or trauma induced wound infections.

• The anticipated funding limit is $2.5M total costs.

• The anticipated maximum period of performance is 3 years.

The National Wetland Conservation Fund (NWCF) supports Canadians in undertaking on-the-ground activities to restore and enhance wetlands in Canada. These activities must take place on private lands, municipal lands, provincial Crown lands, federal Crown lands in the Northwest Territories, Yukon, and Nunavut, or Aboriginal land across Canada.

The NWCF is one of several funding programs operated by Environment Canada for the conservation of natural habitats and wildlife. You can only receive funding from one federal funding program for each proposed activity. Any proposals submitted to the other federal funding programs, (Habitat Stewardship Program, Aboriginal Fund for Species at Risk, EcoAction, etc.) must be for different activities than those listed in your NWCF proposal.

Timelines

The program will be accepting expressions of interest until December 18, 2015. The submission of an expression of interest is strongly encouraged, particularly for applicants who have not received NWCF funding in the past.

The deadline for proposal submissions is January 15, 2016

The Operating Grants competition is the principal means by which the Cancer Research Society fulfills its mission to support fundamental, early translational and Environment-Cancer research on all types of cancer in order to contribute to the advancement of science aimed at preventing, detecting and treating this disease.

The Canadian TREE Fund (CTF) is a registered Canadian charity established to promote arboriculture research in Canada. Research grants have been awarded nationwide for worthy projects. Individuals and/or agencies are invited to submit proposals for consideration. The scope of your proposal can vary in size with this grant being the sole source of funding or one of a variety of sources. The project will be evaluated with regard for the goals of the TREE Fund as a whole and the impact that can be made with each grant.

Ontario Genomics is pleased to announce that Genome Canada, in partnership with the Canadian Institutes of Health Research (CIHR), is seeking proposals for research projects to address any aspect of bioinformatics and computational biology (B/CB) as it relates to genomics. Proposals with applications across all of Genome Canada’s sectors are welcome. These include agriculture & agri-food, fisheries & aquaculture, forestry, energy, environment, human health and mining.

Genome Canada has identified B/CB as a priority area with the goal to create an environment that supports the creation and evolution of enhanced B/CB tools and methodologies. In August 2015, a B/CB Advisory Committee struck by Genome Canada and CIHR released a consultative version of a Strategic Framework for the future of B/CB in Canada. This competition builds on Genome Canada’s 2012 B/CB competition, also in partnership with CIHR, and seeks to advance the objectives of the proposed B/CB national strategy.

The major objectives of this Request for Applications (RFA) are to:

1. Support the development of next generation Bioinformatics and Computational Biology tools and methodologies that will be required by the research community to deal with the influx of large amounts of data produced by modern genomics technologies; and,
2. Provide broad access of these new Bioinformatics and Computational Biology tools to the research community.

Competition timeline